Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 18, 2026 | Capital Blue Cross | Power Wheelchairs, Power Operated Vehicles (POV) and Related Options and AccessoriesPayerPolicy · CAPBLUE-MP-6.037 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Polysomnography for Non-Respiratory Sleep DisordersPayerPolicy · CAPBLUE-MP-2.335 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Placental/Umbilical Cord Blood as Source of Stem CellsPayerPolicy · CAPBLUE-MP-9.001 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Periureteral Bulking Agents as Treatment of Vesicoureteral RefluxPayerPolicy · CAPBLUE-MP-1.109 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Orphan Drugs and Humanitarian Use DevicesPayerPolicy · CAPBLUE-MP-2.383 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Ophthalmologic Techniques That Evaluate the Posterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.056 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Nonpharmacologic Treatment of RosaceaPayerPolicy · CAPBLUE-MP-2.071 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Navigated Transcranial Stimulation (nTMS)PayerPolicy · CAPBLUE-MP-2.094 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN)PayerPolicy · CAPBLUE-MP-2.377 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Medical NecessityPayerPolicy · CAPBLUE-MP-4.003 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Medical Management of Obstructive Sleep Apnea SyndromePayerPolicy · CAPBLUE-MP-6.064 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Mechanical Insufflation Exsufflation DevicePayerPolicy · CAPBLUE-MP-6.022 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Measurement of Exhaled Nitric Oxide in the Diagnosis and Management of Asthma and Other Respiratory DisordersPayerPolicy · CAPBLUE-MP-4.038 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Manual Wheelchairs and AccessoriesPayerPolicy · CAPBLUE-MP-6.059 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Magnetic Resonance-Guided Focused UltrasoundPayerPolicy · CAPBLUE-MP-5.053 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Lung and Lobar Lung TransplantPayerPolicy · CAPBLUE-MP-9.015 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Low Level Laser TherapyPayerPolicy · CAPBLUE-MP-1.097 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Liver Transplant and Combined Liver-Kidney TransplantPayerPolicy · CAPBLUE-MP-9.006 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Knee BracesPayerPolicy · CAPBLUE-MP-6.012 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Kidney Transplants, Pancreas Transplants, and Simultaneous Kidney/Pancreas TransplantPayerPolicy · CAPBLUE-MP-9.005 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | JAK2, MPL, and CLR Mutation Analysis in Myeloproliferative NeoplasmsPayerPolicy · CAPBLUE-MP-2.281 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Isolated Small Bowel Transplant and Small Bowel/Liver and Multivisceral TransplantPayerPolicy · CAPBLUE-MP-9.013 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Islet TransplantationPayerPolicy · CAPBLUE-MP-9.012 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Intravitreal and Punctum Corticosteroid ImplantsPayerPolicy · CAPBLUE-MP-2.159 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric DisordersPayerPolicy · CAPBLUE-MP-2.167 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Intraocular Lenses, Spectacle Correction,and Iris ProsthesisPayerPolicy · CAPBLUE-MP-6.058 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Intensive Pediatric Feeding ProgramsPayerPolicy · CAPBLUE-MP-2.079 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Injectable Bulking Agents for the Treatment of Urinary and Fecal IncontinencePayerPolicy · CAPBLUE-MP-4.012 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Implantable Bone-Conduction and Bone-Anchored Hearing Prosthetic DevicesPayerPolicy · CAPBLUE-MP-1.019 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hyperbaric Oxygen Therapy (HBO) (Formerly Hyperbaric Oxygen Pressurization)PayerPolicy · CAPBLUE-MP-2.070 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation in the Treatment of Germ-Cell TumorsPayerPolicy · CAPBLUE-MP-9.052 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · CAPBLUE-MP-9.045 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · CAPBLUE-MP-9.044 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · CAPBLUE-MP-9.043 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for CNS Embryonal Tumors and EpendymomaPayerPolicy · CAPBLUE-MP-9.050 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · CAPBLUE-MP-9.040 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Heart/Lung TransplantPayerPolicy · CAPBLUE-MP-9.014 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Germline Genetic Testing for Pancreatic Cancer Susceptibility GenesPayerPolicy · CAPBLUE-MP-2.392 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Germline And Somatic Biomarker Testing (Including Liquid Biopsy) For Targeted Treatment In Prostate Cancer (Brca1/2, Homologous Recombination Repair Gene Alterations, Ntrk Gene Fusion)PayerPolicy · CAPBLUE-MP-2.394 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Germline And Somatic Biomarker Testing (Including Liquid Biopsy) For Targeted Treatment In Ovarian Cancer (Brca1, Brca2, Homologous Recombination Deficiency, Ntrk)PayerPolicy · CAPBLUE-MP-2.395 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing of CADASIL SyndromePayerPolicy · CAPBLUE-MP-2.247 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Predisposition to Inherited Hypertrophic CardiomyopathyPayerPolicy · CAPBLUE-MP-2.248 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for PTEN Hamartoma Tumor SyndromePayerPolicy · CAPBLUE-MP-2.255 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for NeurofibromatosisPayerPolicy · CAPBLUE-MP-2.358 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related DisordersPayerPolicy · CAPBLUE-MP-2.331 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Li-Fraumeni SyndromePayerPolicy · CAPBLUE-MP-2.274 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Idiopathic Dilated CardiomyopathyPayerPolicy · CAPBLUE-MP-2.328 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Heterozygous Familial HypercholesterolemiaPayerPolicy · CAPBLUE-MP-2.363 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Hereditary PancreatitisPayerPolicy · CAPBLUE-MP-2.318 | Criteria changed |
|---|
| May 18, 2026 | Capital Blue Cross | Genetic Testing for Hereditary HemochromatosisPayerPolicy · CAPBLUE-MP-2.312 | Criteria changed |
|---|